Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,203 trials

NCT06294548
Recruiting
A Study of Valemetostat Tosylate (DS-3201b) With Atezolizumab and Bevacizumab in HCC
Phase 1/2 · United States · 1 site
Registry update: 1 Sept 2026
NCT07021495
Recruiting
SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)
Not applicable · Netherlands · 8 sites
Registry update: 19 Aug 2025
NCT07083206
Recruiting
A Study to Evaluate the Effectiveness and Safety of Fixed-Dose Combination of Pitavastatin/ Ezetimibe
Not applicable · South Korea · 1 site
Registry update: 27 Oct 2026
NCT07097961
Recruiting
Paediatric Post-TB Pulmonary Rehab Study
Not applicable · Uganda · 1 site
Registry update: 11 Aug 2025
NCT07091864
Recruiting
Continuous Glucose Monitoring for the Management of Hyperglycemia in Patients With Glioblastoma
Not applicable · United States · 3 sites
Registry update: 17 Aug 2026
NCT06543576
Recruiting
External Beam Radiation Therapy and Brachytherapy With Chemotherapy and Immunotherapy for the Treatment of Stage IVB Cervical Cancer
Phase 1/2 · United States · 4 sites
Registry update: 12 Aug 2026
NCT07115043
Recruiting
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
Phase 1/2 · Australia, Japan, South Korea, United States · 10 sites
Registry update: 8 Oct 2026
NCT06852248
Recruiting
Ureteric Identification Using Indocyanine Green Dye Versus Conventional Ureteric Stenting to Reduce Post-operative Pain and Surgical Morbidity During Endometriosis Surgery
Not applicable · United Kingdom · 1 site
Registry update: 3 Sept 2025
NCT07868614
Recruiting
Intraoperative Microelectrode Recordings Using MAVEN Compared to Standard Recording Apparatuses
Not applicable · United States · 1 site
Registry update: 9 Oct 2026
NCT06917573
Recruiting
PALACE: Cemiplimab Trial According to ctDNA Levels
Phase 2 · Spain · 20 sites
Registry update: 19 Nov 2025
NCT07361029
Recruiting
CD19 Chimeric Antigen Receptor (CAR) T Cells in Adults With Relapsed/Refractory CD19 Positive Acute Lymphoblastic Leukemia
Phase 1 · Saudi Arabia · 1 site
Registry update: 22 Jan 2026
NCT07091526
Recruiting
Whether Control of Serum Uric Acid (SUA) Improves Survival After Pancreatic Cancer
Not applicable · China · 1 site
Registry update: 19 Dec 2025
NCT07009171
Recruiting
Study to Evaluate the Efficacy and Safety of KDS2010 in Overweight or Obese Patients
Phase 2 · South Korea · 3 sites
Registry update: 24 Jun 2026
NCT07090317
Recruiting
Iparomlimab and Tuvonralimab in HNSCC
Phase 2 · China · 1 site
Registry update: 18 Jun 2026
NCT07114770
Recruiting
Explore the Impacts of One Session and Multiple Session Theta Burst Stimulation Over Cerebellum in Adults With Autism Spectrum Disorder
Not applicable · Taiwan · 1 site
Registry update: 11 Aug 2025
NCT07088211
Recruiting
Sacituzumab Tirumotecan and Toripalimab in the First-line Treatment of HNSCC
Phase 2 · China · 1 site
Registry update: 18 Jun 2026
NCT06328608
Recruiting
A Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Children and Adolescents With Fabry Disease
Phase 2/3 · Austria, Spain, France, United Kingdom, Norway, United States · 12 sites
Registry update: 10 Aug 2026
NCT07170748
Recruiting
Clinical Performance Evaluation of MagIA IVD-MD Multiplex Testing (HIV/HBV/HCV/Syphilis)
Not applicable · Côte d’Ivoire, Kenya · 2 sites
Registry update: 2 Feb 2026
NCT06962787
Recruiting
A Study of BL-B01D1+TKI±Pembrolizumab in Patients With Locally Advanced or Metastatic Renal Cancer
Phase 2 · China · 1 site
Registry update: 17 Nov 2025
NCT06348108
Recruiting
Talquetamab in Combination With Iberdomide and Dexamethasone for Relapsed or Refractory Multiple Myeloma
Phase 1 · United States · 1 site
Registry update: 13 Mar 2026

Ordered by registry start date. Freshness and sponsorship never change the order.